Low rate of seroconversion in a retrospective study analyzing QuantiFERON TB-gold testing in psoriasis and hidradenitis suppurativa patients taking biologic therapy at an academic center in New York City
Published: 19 December 2023| Version 1 | DOI: 10.17632/t4mj454jwy.1
Contributors:
Apostolos Katsiaunis, Jade Conway, Debra D'Angelo, Shari LipnerDescription
Low rate of seroconversion in a retrospective study analyzing QuantiFERON TB-gold testing in psoriasis and hidradenitis suppurativa patients taking biologic therapy at an academic center in New York City
Files
Categories
Biologic Therapy, Psoriasis, Hidradenitis Suppurativa